Not applicableStudy completedNCT03192683What this trial is testingModified "Providence" Pedi Cast-Sling vs.Cast and SlingWho this might be right forFractures, BonePediatric ALL Lifespan 71
Early research (Phase 1)WithdrawnNCT04094766What this trial is testingSafety and Efficacy of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy in R/R Acute B Lymphoblastic LeukemiaWho this might be right forRefractory B Acute Lymphoblastic LeukemiaRelapse B Acute Lymphoblastic Leukemia Second Affiliated Hospital of Xi'an Jiaotong University
Not applicableActive Not RecruitingNCT06723496What this trial is testingPsychiatric Problems in Children With Acute Lymphoblastic Leukemia and Their CaregiversWho this might be right forAcute Lymphoblastic Leukemia ALL Assiut University 90
Early research (Phase 1)Study completedNCT00036946What this trial is testingVEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific Regeneron Pharmaceuticals
Not applicableNot Yet RecruitingNCT06902025What this trial is testingJY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell LeukemiaWho this might be right forB-ALL He Huang 24
Early research (Phase 1)Study completedNCT02529813What this trial is testingCD19-Specific T-cells in Treating Patients With Advanced Lymphoid MalignanciesWho this might be right forAcute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaBlasts 5 Percent or More of Bone Marrow Nucleated Cells+6 more M.D. Anderson Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT01466179What this trial is testingClinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia Amgen Research (Munich) GmbH 225
Post-approval studies (Phase 4)Study completedNCT03677596What this trial is testingTwo Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible PatientsWho this might be right forLeukemiaPrecursor b-Cell Lymphoblastic Leukemia-LymphomaACUTE LYMPHOBLASTIC LEUKEMIA Pfizer 102
Testing effectiveness (Phase 2)UnknownNCT02660762What this trial is testingModified MRCUKALLⅫ/ECOGE2993 Regimen for ALLWho this might be right forLeukaemia,Lymphoblastic Sun Yat-sen University 100
Not applicableEnded earlyNCT00967525What this trial is testingIntraosseous Infusion of Unrelated Cord Blood GraftsWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+1 more Emory University 5
Large-scale testing (Phase 3)UnknownNCT00445497What this trial is testingEarly Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile NeutropeniaWho this might be right forBrain and Central Nervous System TumorsLymphomaNeutropenia+3 more Clatterbridge Centre for Oncology 400
Early research (Phase 1)Study completedNCT00470197What this trial is testingFlavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute LeukemiaWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more National Cancer Institute (NCI) 35
Large-scale testing (Phase 3)Active Not RecruitingNCT03914625What this trial is testingInvestigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaB Lymphoblastic LymphomaDown Syndrome National Cancer Institute (NCI) 6,720
Not applicableStudy completedNCT05587582What this trial is testingBehavioral Parenting Skills As A Novel Target for Improving Pediatric Medication AdherenceWho this might be right forAcute Lymphoblastic Leukemia Roswell Park Cancer Institute 51
Post-approval studies (Phase 4)Ended earlyNCT05071482What this trial is testingFlumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALLWho this might be right forAcute Leukemia Institute of Hematology & Blood Diseases Hospital, China 39
Early research (Phase 1)Study completedNCT00390117What this trial is testingAT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific NCIC Clinical Trials Group 34
Early research (Phase 1)Study completedNCT00588991What this trial is testingVeliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative DisordersWho this might be right forAdult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Ended earlyNCT00941928What this trial is testingHaploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)Who this might be right forLeukemiaPediatric Cancer M.D. Anderson Cancer Center 2
Early research (Phase 1)Looking for participantsNCT05679895What this trial is testingSafety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LLWho this might be right forT-cell Acute Lymphoblastic LeukemiaLymphoblastic T-Cell Lymphoma OneChain Immunotherapeutics 20
Not applicableStudy completedNCT00281801What this trial is testingCaregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Case Comprehensive Cancer Center 168